The group is looking ahead with optimism as human tissue testing is becoming mission critical to the pharmaceutical industry. Asterand is well placed in a market that is growing.
Only registred members can create thier own customized alerts.
-
-
18/02/10
Asterand completes BioSeek acquisition marking first step in ‘buy-and-build’ strategy
Asterand announced its plan to buy the privately-held BioSeek for up to US$14 million in cash and shares, back in November 2009.
-
18/11/09
Asterand to buy US drug discovery services group BioSeek, 9 mths trading ‘encouraging’
Asterand PLC (LSE: ATD) reported encouraging trading for the first nine months and announced it plans to buy privately-held US drug discovery services company BioSeek Inc for up to US$14 million in cash and shares.
-
17/12/08
Asterand – on the cusp of profitability
Asterand is a healthcare services business that supplies human tissue and tissue-based research services to drug discovery organisations. -
